Corsi Alessandro, Collins Michael T, Riminucci Mara, Howell Peter G T, Boyde Alan, Robey Pamela Gehron, Bianco Paolo
Dipartimento di Medicina Sperimentale, Universitá dell'Aquila, L'Aquila, Italy.
J Bone Miner Res. 2003 Jul;18(7):1235-46. doi: 10.1359/jbmr.2003.18.7.1235.
Deposition, mineralization, and resorption of FD bone compared with unaffected bone from FD patients was investigated in iliac crest biopsy specimens from 13 patients. Compared with unaffected bone, lesional FD bone seemed to be very sensitive to the effects of PTH and renal phosphate wasting, which respectively bring about hyperparathyroid or osteomalacic changes in the lesional bone.
Fibrous dysplasia is a genetic noninherited disease caused by activating mutations of the GNAS1 gene, resulting in the deposition of qualitatively abnormal bone and marrow. This study was designed to learn more about the local processes of bone deposition, mineralization, and resorption within lesional fibrous dysplasia (FD) bone compared with unaffected bone of FD patients.
Histology, histomorphometry, and quantitative back-scattered electron imaging (qBSE) analysis was conducted on affected and unaffected biopsy specimens from 13 patients and correlated to markers of bone metabolism.
There was a marked excess of unmineralized osteoid with a nonlamellar structure and a reduced mineral content in mineralized bone within FD lesions (p < 0.001). A negative correlation (p = 0.05) between osteoid thickness (O.Th) and renal tubular phosphate reabsorption (measured as TmP/GFR) was observed for lesional bone, but not for unaffected bone, in which no histological or histomorphometric evidence of osteomalacia was observed in patients with renal phosphate wasting. Histological and histomorphometric evidence of increased bone resorption was variable in lesional bone and correlated with serum levels of parathyroid hormone (PTH). Hyperparathyroidism-related histological changes were observed in fibrous dysplastic bone, but not in the unaffected bone, of patients with elevated serum PTH secondary to vitamin D deficiency. Our data indicate that, compared with unaffected bone, lesional FD bone is very sensitive to the effects of PTH and renal phosphate wasting, which, respectively, bring about hyperparathyroid or osteomalacic changes in the lesional bone. Osteomalacic and hyperparathyroid changes, which emanate from distinct metabolic derangements (which superimpose on the local effects of GNAS1 mutations in bone), influence, in turn, the severity and type of skeletal morbidity in FD.
在13例患者的髂嵴活检标本中,研究了纤维发育不良(FD)骨与FD患者未受影响骨相比的沉积、矿化和吸收情况。与未受影响的骨相比,FD病变骨似乎对甲状旁腺激素(PTH)和肾性磷酸盐消耗的影响非常敏感,这分别导致病变骨出现甲状旁腺功能亢进或骨软化改变。
纤维发育不良是一种由GNAS1基因激活突变引起的遗传性非遗传性疾病,导致性质异常的骨和骨髓沉积。本研究旨在更深入了解病变性纤维发育不良(FD)骨与FD患者未受影响骨相比的骨沉积、矿化和吸收的局部过程。
对13例患者的病变和未受影响的活检标本进行组织学、组织形态计量学和定量背散射电子成像(qBSE)分析,并与骨代谢标志物相关联。
FD病变内未矿化类骨质明显过多,结构无板层状,矿化骨中的矿物质含量降低(p<0.001)。在病变骨中观察到类骨质厚度(O.Th)与肾小管磷酸盐重吸收(以TmP/GFR衡量)之间呈负相关(p=0.05),而在未受影响的骨中未观察到这种相关性,在肾性磷酸盐消耗患者的未受影响骨中未观察到骨软化的组织学或组织形态计量学证据。病变骨中骨吸收增加的组织学和组织形态计量学证据各不相同,且与血清甲状旁腺激素(PTH)水平相关。在继发于维生素D缺乏且血清PTH升高的患者中,在纤维发育不良骨中观察到与甲状旁腺功能亢进相关的组织学改变,但在未受影响的骨中未观察到。我们的数据表明,与未受影响的骨相比,FD病变骨对PTH和肾性磷酸盐消耗的影响非常敏感,这分别导致病变骨出现甲状旁腺功能亢进或骨软化改变。骨软化和甲状旁腺功能亢进改变源于不同的代谢紊乱(叠加在骨中GNAS1突变的局部影响上),反过来又影响FD骨骼疾病的严重程度和类型。